0001493152-21-009294.txt : 20210420
0001493152-21-009294.hdr.sgml : 20210420
20210420213517
ACCESSION NUMBER: 0001493152-21-009294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210416
FILED AS OF DATE: 20210420
DATE AS OF CHANGE: 20210420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silverman Joshua
CENTRAL INDEX KEY: 0001524858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 21839295
MAIL ADDRESS:
STREET 1: IROQUOIS CAPITAL MANAGEMENT LLC
STREET 2: 205 EAST 42ND ST - 20TH FL.
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences, Inc.
DATE OF NAME CHANGE: 20170413
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
4
1
ownership.xml
X0306
4
2021-04-16
0
0001321834
MyMD Pharmaceuticals, Inc.
MYMD
0001524858
Silverman Joshua
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK,
NY
10036
1
0
0
0
Common Stock
2021-04-16
4
M
0
109500
A
112101
D
Common Stock
2021-04-16
4
F
0
38325
4.94
D
71175
D
Restricted Stock Units
2021-04-16
4
M
0
109500
0.00
D
Common Stock
109500
0
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company").
Represents 38,325 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 109,500 shares of RSUs on April 16, 2021.
On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control.
/s/ Joshua Silverman
2021-04-20